Femasys Inc. (FEMY)

$1.22

-0.05 (-3.94%)
Rating:
Recommendation:
-
Symbol FEMY
Price $1.22
Beta 0.000
Volume Avg. 0.02M
Market Cap 14.413M
Shares () -
52 Week Range 0.57-3.71
1y Target Est -
DCF Unlevered FEMY DCF ->
DCF Levered FEMY LDCF ->
ROE -52.45% Strong Sell
ROA -58.10% Strong Sell
Operating Margin -
Debt / Equity 11.25% Neutral
P/E 4.07 Buy
P/B 0.80 Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest FEMY news


Healthcare
Medical Instruments & Supplies
NASDAQ Capital Market

Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.